PRTX-100: Phase I/II started

Protalex began the open-label, dose-escalation, U.S. Phase I/II PRTX-100-202 Study to evaluate 1, 3, 6, 12, 18 and 24 ug/kg IV PRTX-100 weekly for 4 weeks in up to 36 patients. ...